ARM Member Profiles

Capstan Therapeutics is advancing precision in vivo engineering in a scalable and controlled format to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need. The core technology comprises targeted Lipid Nanoparticles (tLNPs) to enable engineering or ablation of pathogenic cells in the body. The company is combining the power of cell therapy with the precision of genetic medicines to deliver breakthrough medicines to patients for oncology, fibrosis, inflammation-related diseases, and monogenic blood disorders. The Company is founded by pioneers in the field of CAR-based immunotherapy, nucleic acid drug delivery, tLNPs, and regenerative medicine, including experienced industry leaders and academic faculty members from the University of Pennsylvania. Capstan has a bicoastal presence with operations in San Diego, CA and Philadelphia, PA.